Hologic (HOLX) Debt/Equity Ratio: History & Chart

Hologic, Inc. (HOLX)HOLXHologic, Inc.

About Hologic, Inc.

Hologic, Inc. is a medical technology company focused on designing, producing, and marketing a diverse range of diagnostic tests, medical imaging systems, and surgical solutions. Its core mission is to enhance women's health through proactive detection and effective treatment, serving patients in the United States, across Europe, the Asia-Pacific region, and various other international markets. The company operates through four distinct business units: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. Within its Diagnostics segment, Hologic provides Aptima molecular diagnostic assays for identifying infectious microorganisms, alongside Aptima viral load tests for conditions like HIV, Hepatitis C, and Hepatitis B. It also offers Aptima and Panther Fusion SARS-CoV-2 assays for detecting the virus, the ThinPrep System for cytology applications, and the Rapid Fetal Fibronectin Test to help clinicians assess the likelihood of premature birth. Furthermore, the company supplies various diagnostic tests for Group B Streptococcus. The Breast Health division delivers advanced imaging and analytical solutions, including 2D and 3D digital mammography systems with accompanying reading workstations. This segment also features minimally invasive breast biopsy guidance systems and devices, products for marking and localizing breast biopsy sites, specimen radiology tools, ultrasound solutions, connectivity options, and products supporting breast-conserving surgical procedures. For GYN Surgical needs, Hologic offers the NovaSure Endometrial Ablation System, designed to manage abnormal uterine bleeding, and the MyoSure Hysteroscopic Tissue Removal System for the excision of uterine fibroids, polyps, and other pathologies. Additionally, the Fluent Fluid Management System facilitates liquid distention during diagnostic and operative hysteroscopic interventions. The Skeletal Health segment includes the Horizon DXA, a dual-energy X-ray system, and the Fluoroscan Insight FD mini C-arm, which is utilized for minimally invasive orthopedic surgical procedures. Hologic distributes its comprehensive product portfolio through a combination of its dedicated direct sales and service teams, as well as via independent distributors and sales representatives. Established in 1985, Hologic, Inc. maintains its corporate headquarters in Marlborough, Massachusetts.

Marlborough, MA

7,063 employees

www.hologic.com

Healthcare / Medical - Instruments & Supplies

Sector: Healthcare
Industry: Medical - Instruments & Supplies
CEO: Paul Malenchini

View full financials

HOLX Debt to Equity Ratio Metrics

DEBT TO EQUITY RATIO

0.48

DEBT TO EQUITY RATIO AVG TTM

0.52

DEBT TO EQUITY RATIO AVG 3Y

0.53

DEBT TO EQUITY RATIO AVG 5Y

0.57

DEBT TO EQUITY RATIO AVG 10Y

0.97

DEBT TO EQUITY RATIO AVG 15Y

1.14

DEBT TO EQUITY RATIO AVG 20Y

0.95

CURRENT VS TTM AVG

-7.67%

CURRENT VS 3Y AVG

-10.04%

CURRENT VS 5Y AVG

-14.98%

CURRENT VS 10Y AVG

-50.60%

CURRENT VS 15Y AVG

-58.00%

CURRENT VS 20Y AVG

-49.53%

SECTOR MEDIAN · HEALTHCARE

0.67

median of 79 covered companies

CURRENT VS SECTOR MEDIAN

-28.28%

vs the sector median at left

NAME	MARKET CAP	DEBT TO EQUITY RATIO	TTM	3Y	5Y
Hologic, Inc. (HOLX)	$16.97B	0.48	0.52	0.53	0.57
Medpace Holdings, Inc. (MEDP)vs ›	$16.79B	0.55	0.36	0.37	0.29
Zimmer Biomet Holdings, Inc. (ZBH)vs ›	$17.67B	0.59	0.54	0.51	0.54
DaVita Inc. (DVA)vs ›	$15.11B	-23.12	55.08	35.65	25.99
Viatris Inc. (VTRS)vs ›	$20.08B	1.00	0.89	0.90	0.98
The Cooper Companies, Inc. (COO)vs ›	$13.71B	0.34	0.33	0.35	0.36
Solventum Corporation (SOLV)vs ›	$13.51B	1.00	1.85	1.11	0.74
STERIS plc (STE)vs ›	$20.86B	0.29	0.31	0.42	0.44
Moderna, Inc. (MRNA)vs ›	$21.45B	0.22	0.15	0.11	0.10
Revvity, Inc. (RVTY)vs ›	$12.32B	0.48	0.45	0.51	0.56

NAME

MARKET CAP

DEBT TO EQUITY RATIO

TTM

Hologic, Inc. (HOLX)

$16.97B

0.48

0.52

0.53

0.57

Medpace Holdings, Inc. (MEDP)vs ›

$16.79B

0.55

0.36

0.37

0.29

Zimmer Biomet Holdings, Inc. (ZBH)vs ›

$17.67B

0.59

0.54

0.51

0.54

DaVita Inc. (DVA)vs ›

$15.11B

-23.12

55.08

35.65

25.99

Viatris Inc. (VTRS)vs ›

$20.08B

1.00

0.89

0.90

0.98

The Cooper Companies, Inc. (COO)vs ›

$13.71B

0.34

0.33

0.35

0.36

Solventum Corporation (SOLV)vs ›

$13.51B

1.00

1.85

1.11

0.74

STERIS plc (STE)vs ›

$20.86B

0.29

0.31

0.42

0.44

Moderna, Inc. (MRNA)vs ›

$21.45B

0.22

0.15

0.11

0.10

Revvity, Inc. (RVTY)vs ›

$12.32B

0.48

0.45

0.51

0.56

Debt to Equity Ratio FAQ

What is the debt to equity ratio for Hologic, Inc. (HOLX)?

The debt to equity ratio for HOLX stock is 0.48.

Is Hologic, Inc.'s debt to equity ratio high or low?

The debt to equity ratio of 0.48 is 18% below its 5-year average of 0.59, near the low end of its 5-year range (0.48–0.81).

What is the TTM average debt to equity ratio for Hologic, Inc. (HOLX)?

The TTM average debt to equity ratio for HOLX stock is 0.52.

What is the 3Y average debt to equity ratio for Hologic, Inc. (HOLX)?

The 3Y average debt to equity ratio for HOLX stock is 0.53.

What is the 5Y average debt to equity ratio for Hologic, Inc. (HOLX)?

The 5Y average debt to equity ratio for HOLX stock is 0.57.

What is the 10Y average debt to equity ratio for Hologic, Inc. (HOLX)?

The 10Y average debt to equity ratio for HOLX stock is 0.97.

What is the 15Y average debt to equity ratio for Hologic, Inc. (HOLX)?

The 15Y average debt to equity ratio for HOLX stock is 1.14.

What is the 20Y average debt to equity ratio for Hologic, Inc. (HOLX)?

The 20Y average debt to equity ratio for HOLX stock is 0.95.

DATE	DEBT TO EQUITY RATIO
2025-12-27	0.48
2025-09-27	0.52
2025-06-28	0.52
2025-03-29	0.55
2024-12-28	0.53
2024-09-30	0.52
2024-06-29	0.52
2024-03-30	0.53
2023-12-30	0.55
2023-09-30	0.58
2023-07-01	0.55
2023-04-01	0.54
2022-12-31	0.56
2022-09-30	0.60
2022-06-25	0.57
2022-03-26	0.65
2021-12-25	0.68
2021-09-30	0.75
2021-06-26	0.81
2021-03-27	0.73
2020-12-26	0.85
2020-09-30	1.16
2020-06-27	1.47
2020-03-28	1.71
2019-12-28	1.37
2019-09-30	1.36
2019-06-29	1.39
2019-03-30	1.45
2018-12-29	1.32
2018-09-30	1.38
2018-06-30	1.34
2018-03-31	1.38
2017-12-30	1.05
2017-09-30	1.21
2017-07-01	1.13
2017-04-01	1.18
2016-12-31	1.49
2016-09-30	1.58
2016-06-25	1.68
2016-03-26	1.67
2015-12-26	1.68
2015-09-30	1.75
2015-06-27	1.76
2015-03-28	1.82
2014-12-27	1.88
2014-09-30	2.09
2014-06-28	2.10
2014-03-29	2.16
2013-12-28	2.21
2013-09-30	2.49
2013-06-29	1.67
2013-03-30	1.67
2012-12-29	1.69
2012-09-30	1.71
2012-06-23	0.51
2012-03-24	0.51
2011-12-24	0.51
2011-09-30	0.52
2011-06-25	0.51
2011-03-26	0.51
2010-12-25	0.52
2010-09-30	0.54
2010-06-26	0.51
2010-03-27	0.52
2009-12-26	0.55
2009-09-30	0.62
2009-06-27	0.82
2009-03-28	0.88
2008-12-27	0.46
2008-09-30	0.47
2008-06-28	0.36
2008-03-29	0.39
2007-12-29	0.44
2007-09-30	0.01
2007-06-30	0.01
2007-03-31	0.01
2006-12-30	0.08
2006-09-30	0.11
2006-06-24	0.20
2006-03-25	0.00
2005-12-24	0.00
2005-09-30	0.00
2005-06-25	0.00
2005-03-26	0.00
2004-12-25	0.00
2004-09-30	0.01
2004-06-26	0.01
2004-03-27	0.01
2003-12-27	0.01
2003-09-30	0.01
2003-06-28	0.01
2003-03-29	0.02
2002-12-28	0.02
2002-09-30	0.02
2002-06-29	0.19
2002-03-30	0.20

DATE

DEBT TO EQUITY RATIO

2025-12-27

0.48

2025-09-27

0.52

2025-06-28

0.52

2025-03-29

0.55

2024-12-28

0.53

2024-09-30

0.52

2024-06-29

0.52

2024-03-30

0.53

2023-12-30

0.55

2023-09-30

0.58

2023-07-01

0.55

2023-04-01

0.54

2022-12-31

0.56

2022-09-30

0.60

2022-06-25

0.57

2022-03-26

0.65

2021-12-25

0.68

2021-09-30

0.75

2021-06-26

0.81

2021-03-27

0.73

2020-12-26

0.85

2020-09-30

1.16

2020-06-27

1.47

2020-03-28

1.71

2019-12-28

1.37

2019-09-30

1.36

2019-06-29

1.39

2019-03-30

1.45

2018-12-29

1.32

2018-09-30

1.38

2018-06-30

1.34

2018-03-31

1.38

2017-12-30

1.05

2017-09-30

1.21

2017-07-01

1.13

2017-04-01

1.18

2016-12-31

1.49

2016-09-30

1.58

2016-06-25

1.68

2016-03-26

1.67

2015-12-26

1.68

2015-09-30

1.75

2015-06-27

1.76

2015-03-28

1.82

2014-12-27

1.88

2014-09-30

2.09

2014-06-28

2.10

2014-03-29

2.16

2013-12-28

2.21

2013-09-30

2.49

2013-06-29

1.67

2013-03-30

1.67

2012-12-29

1.69

2012-09-30

1.71

2012-06-23

0.51

2012-03-24

0.51

2011-12-24

0.51

2011-09-30

0.52

2011-06-25

0.51

2011-03-26

0.51

2010-12-25

0.52

2010-09-30

0.54

2010-06-26

0.51

2010-03-27

0.52

2009-12-26

0.55

2009-09-30

0.62

2009-06-27

0.82

2009-03-28

0.88

2008-12-27

0.46

2008-09-30

0.47

2008-06-28

0.36

2008-03-29

0.39

2007-12-29

0.44

2007-09-30

0.01

2007-06-30

0.01

2007-03-31

0.01

2006-12-30

0.08

2006-09-30

0.11

2006-06-24

0.20

2006-03-25

0.00

2005-12-24

0.00

2005-09-30

0.00

2005-06-25

0.00

2005-03-26

0.00

2004-12-25

0.00

2004-09-30

0.01

2004-06-26

0.01

2004-03-27

0.01

2003-12-27

0.01

2003-09-30

0.01

2003-06-28

0.01

2003-03-29

0.02

2002-12-28

0.02

2002-09-30

0.02

2002-06-29

0.19

2002-03-30

0.20

Debt to Equity Ratio: 0.48

HOLX Debt to Equity Ratio

HOLX Average Debt to Equity Ratio Chart

HOLX Current vs Average Debt to Equity Ratio Chart

HOLX Debt to Equity Ratio Metrics

HOLX Competitors' Debt to Equity Ratio

Financial Health

Debt to Equity Ratio Formula & Definition

Debt to Equity Ratio FAQ

HOLX Debt to Equity Ratio History

Related Metrics